此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Strain Counterstrain Versus Graston Technique for Patellofemoral Pain Syndrome (SCS-GRAS-PFPS)

2026年5月10日 更新者:Saman Bukish Cheema、Green International University

Immediate Effects of Strain CountetStrain Versus Graston Technique on Pain and Range of Motion in Patients With Patellofemoral Pain Syndrome: A Randomized Clinical Trail.

This clinical trial compares the effects of Strain Counterstrain technique versus Graston Technique on pain and range of motion in patients with patellofemoral pain syndrome.

Adults with patellofemoral pain syndrome were included in this study. A total of 60 participants were divided into two groups with 30 patients in each group.

One group received Strain Counterstrain technique and the other group received Graston Technique. Pain was assessed using the Kujala Scoring System and functional status was measured using a substructural questionnaire. Range of motion was also evaluated before and after treatment.

The main goal of this study is to determine which technique is more effective in reducing pain and improving knee function in patients with patellofemoral pain syndrome.

研究概览

详细说明

Patellofemoral Pain Syndrome (PFPS) is a common musculoskeletal condition characterized by anterior knee pain, especially during activities like squatting, climbing stairs, or prolonged sitting. Conservative management through manual therapy is widely used, but comparative effectiveness of different techniques remains unclear.

This randomized clinical trial was designed to compare the effects of Strain Counterstrain (SCS) technique versus Graston Technique on pain intensity, knee range of motion, and functional status in patients diagnosed with patellofemoral pain syndrome.

A total of 60 participants diagnosed with PFPS were recruited and randomly allocated into two equal groups, with 30 patients in each group. Group A received Strain Counterstrain technique, which involves passive positioning of the affected tissue to achieve a position of comfort and reduce tender point sensitivity. Group B received Graston Technique, an instrument-assisted soft tissue mobilization (IASTM) therapy that uses specialized stainless steel instruments to detect and treat soft tissue restrictions, scar tissue, and fascial adhesions around the knee.

The intervention period lasted for 12 weeks with 3 sessions per week. Outcome measures were assessed at baseline and post-intervention. Pain was evaluated using the Kujala Anterior Knee Pain Scale, also known as the Kujala Scoring System, which is a validated tool for PFPS. Functional status was assessed using a substructural questionnaire evaluating daily activities. Knee range of motion was measured using a standard goniometer.

The primary objective of this study is to determine whether Strain Counterstrain or Graston Technique provides superior outcomes in terms of pain reduction, improved range of motion, and enhanced functional capacity in patients with patellofemoral pain syndrome. The findings will help clinicians select the most effective manual therapy approach for managing PFPS.

研究类型

介入性

注册 (实际的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Punjab Province
      • Lahore、Punjab Province、巴基斯坦、54000
        • Sir Ganga Ram Hospital, Department of Physical Therapy

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

不

描述

Inclusion Criteria:

  • Age 18-45 years.
  • Anterior or peripatellar knee discomfort reproduced by a minimum of two aggravating exercises (e.g., squatting, stairs, running, prolonged sitting).
  • No history of trauma.
  • On the Numerical Pain Rating Scale (NPRS), pain severity is ≥3/10 at baseline.
  • Symptom duration ≥2 months.
  • Ability to understand instructions and provide informed consent (or parental consent for minors).

Exclusion Criteria:

  • Individuals who have had lower limb surgery within the previous 12 months
  • Existence of other knee pathologies (e.g., meniscal tear with locking, tibiofemoral osteoarthritis, inflammatory arthritis).
  • Skin infection, open wound, or dermatological condition at the treatment site.
  • Use of anticoagulants/bleeding disorders or recent corticosteroid injection within 3 months.
  • Receipt of manual therapy (SCS, IASTM/Graston) to the affected knee within the past 4 weeks.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
实验性的:Strain Counterstrain Group
Participants in this arm received Strain Counterstrain technique for patellofemoral pain syndrome. This technique involves identifying tender points and passively positioning the affected tissue to a position of comfort to reduce pain and muscle spasm. Treatment sessions were administered 3 times per week for 12 weeks. 30 participants were assigned to this group.
Strain Counterstrain is a manual therapy technique that involves identifying tender points in muscles and fascia. The therapist passively positions the patient's body to a position of comfort that reduces or eliminates the tenderness. This position is held for 90 seconds to allow neuromuscular reset, followed by slow return to neutral. The technique aims to reduce muscle spasm, normalize proprioceptive activity, and decrease pain in patients with patellofemoral pain syndrome. Sessions were administered 3 times per week for 12 weeks.
其他名称:
  • 南海公司
  • Positional Release Therapy
实验性的:Graston Technique Group
Participants in this arm received Graston Technique, an instrument-assisted soft tissue mobilization (IASTM) therapy. This technique uses specialized stainless steel instruments to detect and treat soft tissue restrictions, scar tissue, and fascial adhesions around the knee. Treatment sessions were administered 3 times per week for 12 weeks. 30 participants were assigned to this group.
Graston Technique is an evidence-based form of instrument-assisted soft tissue mobilization (IASTM). It uses six specialized stainless steel instruments to scan, detect, and treat soft tissue lesions, scar tissue, and fascial restrictions. The instruments are used by trained clinicians to apply controlled microtrauma to affected areas around the knee, promoting tissue healing and remodeling. The goal is to break down adhesions, reduce pain, and improve range of motion and function in patients with patellofemoral pain syndrome. Sessions were administered 3 times per week for 12 weeks.
其他名称:
  • 国际标准协会
  • 仪器辅助软组织动员

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in Pain and Function using Kujala Anterior Knee Pain Scale
大体时间:Baseline and 12 weeks post-intervention
The Kujala Anterior Knee Pain Scale, also known as Kujala Scoring System, was used to assess pain and functional limitations related to patellofemoral pain syndrome. This is a 13-item self-administered questionnaire evaluating symptoms such as pain during walking, stair climbing, squatting, running, and prolonged sitting. The total score ranges from 0 to 100 points, where 0 represents complete disability and 100 represents no disability. A higher score indicates less pain and better knee function. Change from baseline was calculated to determine treatment effectiveness.
Baseline and 12 weeks post-intervention

次要结果测量

结果测量
措施说明
大体时间
Change in Knee Range of Motion
大体时间:Baseline and 12 weeks post-intervention
Knee flexion and extension range of motion was measured using a standard universal goniometer. Active range of motion was recorded in degrees. Increased range of motion indicates improvement in knee function.
Baseline and 12 weeks post-intervention
Change in Functional Status
大体时间:Baseline and 12 weeks post-intervention
Functional status was assessed using a substructural questionnaire evaluating the impact of patellofemoral pain syndrome on daily activities such as walking, stair climbing, squatting, and prolonged sitting. Higher scores indicate better functional capacity.
Baseline and 12 weeks post-intervention

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年11月2日

初级完成 (实际的)

2026年4月29日

研究完成 (实际的)

2026年5月5日

研究注册日期

首次提交

2026年5月10日

首先提交符合 QC 标准的

2026年5月10日

首次发布 (实际的)

2026年5月15日

研究记录更新

最后更新发布 (实际的)

2026年5月15日

上次提交的符合 QC 标准的更新

2026年5月10日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

Only IPD used in the results publication will be shared.

IPD 共享时间框架

It will be available after the completion of the study.

IPD 共享访问标准

Data requests should be sent to the corresponding author. Access will be granted to qualified researchers for approved research proposals. Data will be de-identified before sharing.

IPD 共享支持信息类型

  • 研究方案
  • 树液
  • 国际碳纤维联合会
  • 企业社会责任

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅